IMPROVING HEALTH IMPROVING LIVES
- Our Values
- Views And Positions
- Our History
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola. For more information, visit www.msd.com
MSD in India
MSD operates its human health business in India through three separate legal entities: MSD Pharmaceuticals Private Limited, Organon (India) Private Limited, and Fulford (India) Limited. Since its existence in India, the company has moved quickly in laying the foundation for a business that is differentiated by its focus through launching innovative products relevant to India. MSD in India also has presence in Animal Health via MSD Animal Health with its vaccines facility located in Pune, Maharashtra.
Key therapeutic areas
MSD in India currently operates in various therapeutic areas in human health, including Metabolics, Vaccines, Critical Care, Oncology, Women's Health, Dermatology, Respiratory, and Primary Care, and offers a strong and diversified product portfolio of over 35 brands. Launching our best in class and first in class products at India specific pricing, and supporting capacity-building initiatives and disease management programs, MSD in India devotes extensive time and energy to increasing access to medicines and vaccines through far-reaching programs and collaborative approach. MSD follows a comprehensive multi-stakeholder approach in all therapeutic areas relevant to our products. We work with partners from the government, non-government and private sectors on innovative approaches to increase access and overcome barriers to healthcare in India.
Commitment to India
At MSD, we are inspired by a shared vision and mission to save and improve lives. MSD has a long term commitment to India both in terms of bringing best in class products and also making necessary investments to serve the Indian patients. MSD will continue in its endeavor to help shape the healthcare paradigms in India through initiatives like responsible pricing, integrated disease management programs; partnerships for research & access; capacity building initiatives, amongst others. In addition to setting up a sales and marketing structure to market best in class products in India, MSD is also coordinating research projects with clinical investigators in India's leading hospitals and universities, for development of new drugs to address unmet medical needs for Indian patients. MSD in India manufactures 80% of the total volume of our products in India through local partners.
Caring for the society we serve
Corporate responsibility at MSD is a commitment to discovering innovative solutions to the world’s greatest health challenges while growing our business in a sustainable way. MSD embraces a commitment to its stakeholders, employees, neighbors, and others in the global communities where it lives and works. In India as well, the Company has a number of Corporate Social Responsibility, Disease Management programs and Capacity building initiatives in order to better serve the interest of patients and communities.